Candesartan Cilexetil and Hydrochlorothiazide
- Generic Name
- Candesartan Cilexetil and Hydrochlorothiazide
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于治疗高血压。但本品不适用于高血压的初始治疗，适用于单用坎地沙坦酯或氢氯噻嗪不能有效控制血压的成年人原发性高血压，或两药联合用药同剂量的替代治疗。
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2010-07-14
- Lead Sponsor
- Takeda
- Target Recruit Count
- 107
- Registration Number
- NCT01012479
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath